SAMSUNG BIOLOGICS CO.,LTD. · 삼성바이오로직스
Last · KSE₩1441000.00-25000.00 (-1.71%)close · yahoo · 12h ago
Market cap₩66.71T46.3M sh
P/E · TTM—fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
₩1228000.00₩1987000.00
Volume26.9Ksession
| Revenue | ₩4.55T |
|---|---|
| Operating income | ₩2.27T |
| Net income | ₩1.98T |
| Free cash flow | ₩1.63T |
| Operating margin | 50.0% |
| Net margin | 43.6% |
| Return on equity | 23.7% |
| Period | TTM 2026-06-30 |
Loading chart…
Upcoming earnings
7:00 AM UTC+1
Period
Sep 2026
Est. EPS
$9,718.00
Est. revenue
1,330.1B
Documents
FormReporting forFiledFlags